Tradestie Institutional Equity Comparison Engine
ABVC vs ALPS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALPS Overall Edge
ALPS Captures Institutional Edge (1โ0 Pillars ยท 3โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ALPS (ALPS) driven by superior Momentum & Technical. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus ALPS at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ALPS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ABVC N/M vs ALPS N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY +104.5% vs +0.0%
Momentum & Technical Winner
ALPS
1Y -68.2% vs +35.3% ยท 52W Pos 7% vs 51%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ABVC
NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap
$23.9M
1M Return
-17.28%
1Y Return
-68.15%
Forward P/E
N/M
Unified AI Score
47.4 / 100
HOLD
Tech 43.0
Fund 50.0
Flow 50.0
Mom 60.0
ALPS
US Equity
ALPS
Institutional Equity
$1.15
-3.36% 1D
Market Cap
$37.7M
1M Return
+250.72%
1Y Return
+35.29%
Forward P/E
N/M
Unified AI Score
31.6 / 100
SELL
Tech 50.0
Fund 29.0
Flow 50.0
Mom 46.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVC -68.15%
ALPS +35.29%
Spread: +103.44 pp (ALPS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVC TTM Op. Margin: 0.0%
ALPS TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs ALPS. Trailing 12-month operating profitability (ABVC 0.0% vs ALPS 0.0%) and valuation multiples (ABVC N/M vs ALPS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVC | ALPS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $23.9M | $37.7M | Larger Scale | ALPS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +104.5% | +0.0% | Higher Growth | ABVC |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -52.7% | 0.0% | Higher ROE | ALPS |
| 52-Week Range Position Momentum | 7% ($1โ$3) | 51% ($0โ$2) | Stronger Trend | ALPS |
| Beta / 30D Volatility Risk Regime | 1.24ฮฒ ยท 44% Vol | 6.25ฮฒ ยท 1362% Vol | Lower Realized Risk | ABVC |
| Unified Institutional Score Composite Signal | 47.4 / 100 (HOLD) | 31.6 / 100 (SELL) | Higher Composite | ABVC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVC vs ALPS Buy Guide
ABVC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ALPS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVC nor ALPS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.